682
Views
37
CrossRef citations to date
0
Altmetric
Articles

Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey

, , , , , , , , , , , & show all
Pages 303-309 | Accepted 06 Nov 2009, Published online: 18 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Zhonghua Yang, Shunping Li, Xuewen Wang & Gang Chen. (2022) Health state utility values derived from EQ-5D in psoriatic patients: a systematic review and meta-analysis. Journal of Dermatological Treatment 33:2, pages 1029-1036.
Read now
Souzan Ezzat Gado, Radwa Moustafa El-Khouly, Marwa Ahmad Aboelhawa, Mohamed Hassan Fouda & Hanaa Samy El-Banna. (2021) The association between IL17, fatigue and quality of life in psoriatic arthritis patients. Expert Review of Clinical Immunology 17:5, pages 539-544.
Read now
Juan Carlos Torre-Alonso, Rubén Queiro, Marta Comellas, Luís Lizán & Carles Blanch. (2018) Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature. Patient Preference and Adherence 12, pages 733-747.
Read now
Haliton Alves de Oliveira Junior, Jéssica Barreto dos Santos, Francisco Assis Acurcio, Alessandra Maciel Almeida, Adriana Maria Kakehasi, Juliana Alvares, Luis Fernando Duarte de Carvalho & Mariangela Leal Cherchiglia. (2015) Poorer functionality is related to better quality of life response following the use of biological drugs: 6-month outcomes in a prospective cohort from the Public Health System (Sistema Único de Saúde), Minas Gerais, Brazil. Expert Review of Pharmacoeconomics & Outcomes Research 15:3, pages 403-412.
Read now

Articles from other publishers (33)

Vineeta Shobha, Chanakya Kodishala, S Chandrashekara, Sharath Kumar, Vikram Haridas, Vijay Rao, Ramesh Jois, Manisha Daware, Yogesh Preet Singh, Shweta Singhai, B G Dharmanad, Pramod Chebbi, R Subramanian, Ashwini Kamath, Uma Karjiigi, Vikramraj K Jain, Chethana Dharmapalaiah, Shiva Prasad, C Srinivas, J Ramya, Benzeeta Pinto, Beenish Nazir, Harshini & Mahendranath. (2023) Impaired Mobility Drives Disability in Psoriatic Arthritis – An Observational Study from Karnataka Psoriatic Arthritis Cohort (KPsAC). Indian Journal of Rheumatology 18:2, pages 120-125.
Crossref
I. F. Fairushina, D. I. Abdulganieva, S. P. McKenna & A. Сoffey. (2023) Psoriatic Arthritis Quality of Life Questionnaire: results of translation, cultural adaptation and validation in Russian language. Modern Rheumatology Journal 17:1, pages 58-63.
Crossref
Senem Bulut, Jale Karakaya, Sevim Oksuz, Umut Kalyoncu & Edibe Unal. (2022) The reliability, validity, and responsiveness of Cognitive Exercise Therapy Approach: Biopsychosocial Questionnaire for patients with psoriatic arthritis. Rheumatology International 42:11, pages 1973-1981.
Crossref
Felipe A. Moraes, Michael R.R. da Silva, Jéssica B.R. dos Santos, Francisco A. Acurcio, Alessandra M. Almeida, Adriana M. Kakehasi & Juliana Alvares-Teodoro. (2021) Health-Related Quality of Life in Psoriatic Arthritis: Findings and Implications. Value in Health Regional Issues 26, pages 135-141.
Crossref
Ying-Ying Leung, Ana-Maria Orbai, Pil Hojgaard, Richard Holland, Ashish J Mathew, Niti Goel, Jeffrey Chau, William Tillett, Christine Lindsay, Alexis Ogdie, Laura C Coates, Dafna D Gladman, Robin Christensen, Philip Mease & Vibeke Strand. (2021) OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF. Seminars in Arthritis and Rheumatism 51:5, pages 1117-1124.
Crossref
Elziane da Cruz Ribeiro e Souza, Sueli Coelho da Silva Carneiro, Michel Alexandre Yazbek, Rita de Cássia Menin, Cristiano Barbosa Campanholo, Jamille Nascimento Carneiro, Carlos Henrique Martis da Silva & Roberto Ranza. (2020) Validation and clinical interpretability of PsAID - psoriatic arthritis impact of disease. Advances in Rheumatology 60:1.
Crossref
Amy D. Zhang & Arthur Kavanaugh. (2019) Treat to Target in Psoriatic Arthritis. Rheumatic Disease Clinics of North America 45:4, pages 505-517.
Crossref
Zsombor Zrubka, Zsuzsanna Beretzky, Zoltán Hermann, Valentin Brodszky, László Gulácsi, Fanni Rencz, Petra Baji, Dominik Golicki, Valentina Prevolnik-Rupel & Márta Péntek. (2019) A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases. The European Journal of Health Economics 20:S1, pages 119-132.
Crossref
Praveena Chiowchanwisawakit, Varalak Srinonprasert, Phakhamon Thaweeratthakul & Wanruchada Katchamart. (2019) Disease activity and functional status associated with health‐related quality of life and patient‐acceptable symptom state in patients with psoriatic arthritis in Thailand: A cross‐sectional study. International Journal of Rheumatic Diseases 22:4, pages 700-707.
Crossref
Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, Philip J Mease, Dafna D Gladman, Linda Chen, Elizabeth Kudlacz, Joseph Wu, Joseph C Cappelleri, Thijs Hendrikx & Ming-Ann Hsu. (2019) Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond. RMD Open 5:1, pages e000808.
Crossref
Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, Philip J Mease, Dafna D Gladman, Daniela Graham, Cunshan Wang, Joseph C Cappelleri, Thijs Hendrikx & Ming-Ann Hsu. (2019) Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden—a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs. RMD Open 5:1, pages e000806.
Crossref
Philip Mease, Vibeke Strand & Dafna Gladman. (2018) Functional impairment measurement in psoriatic arthritis: Importance and challenges. Seminars in Arthritis and Rheumatism 48:3, pages 436-448.
Crossref
Pil Højgaard, Louise Klokker, Ana-Maria Orbai, Kim Holmsted, Else M. Bartels, Ying Ying Leung, Niti Goel, Maarten de Wit, Dafna D. Gladman, Philip Mease, Lene Dreyer, Lars E. Kristensen, Oliver FitzGerald, William Tillett, Laure Gossec, Philip Helliwell, Vibeke Strand, Alexis Ogdie, Caroline B. Terwee & Robin Christensen. (2018) A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative. Seminars in Arthritis and Rheumatism 47:5, pages 654-665.
Crossref
John L. O'Dwyer, David M. Meads, Claire T. Hulme, Lucy Mcparland, Sarah Brown, Laura C. Coates, Anna R. Moverley, Paul Emery, Philip G. Conaghan & Philip S. Helliwell. (2018) Cost-Effectiveness of Tight Control of Inflammation in Early Psoriatic Arthritis: Economic Analysis of a Multicenter Randomized Controlled Trial. Arthritis Care & Research 70:3, pages 462-468.
Crossref
Zsombor Zrubka, Fanni Rencz, Jakub Závada, Dominik Golicki, Valentina Prevolnik Rupel, Judit Simon, Valentin Brodszky, Petra Baji, Guenka Petrova, Alexandru Rotar, László Gulácsi & Márta Péntek. (2017) EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis. Rheumatology International 37:12, pages 1957-1977.
Crossref
Mark Corbett, Fadi Chehadah, Mousumi Biswas, Thirimon Moe-Byrne, Stephen Palmer, Marta Soares, Matthew Walton, Melissa Harden, Pauline Ho, Nerys Woolacott & Laura Bojke. (2017) Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation. Health Technology Assessment 21:56, pages 1-326.
Crossref
Dafna D. Gladman, Yves Poulin, Karen Adams, Marc Bourcier, Snezana Barac, Kirk Barber, Vinod Chandran, Jan Dutz, Cathy Flanagan, Melinda J. Gooderham, Wayne P. Gulliver, Vincent C. Ho, Chih-Ho Hong, Jacob Karsh, Majed M. Khraishi, Charles W. Lynde, Kim A. Papp, Proton Rahman, Sherry Rohekar, Cheryl F. Rosen, Anthony S. Russell, Ronald B. Vender, Jensen Yeung, Olga Ziouzina & Michel Zummer. (2017) Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice. The Journal of Rheumatology 44:4, pages 519-534.
Crossref
Juergen Braun. (2016) New targets in psoriatic arthritis. Rheumatology 55:suppl 2, pages ii30-ii37.
Crossref
Fanni Rencz, László Gulácsi, Michael Drummond, Dominik Golicki, Valentina Prevolnik Rupel, Judit Simon, Elly A. Stolk, Valentin Brodszky, Petra Baji, Jakub Závada, Guenka Petrova, Alexandru Rotar & Márta Péntek. (2016) EQ-5D in Central and Eastern Europe: 2000–2015. Quality of Life Research 25:11, pages 2693-2710.
Crossref
Ana-Maria Orbai & Alexis Ogdie. (2016) Patient-Reported Outcomes in Psoriatic Arthritis. Rheumatic Disease Clinics of North America 42:2, pages 265-283.
Crossref
N. Betteridge, W.‐H. Boehncke, C. Bundy, L. Gossec, J. Gratacós & M. Augustin. (2015) Promoting patient‐centred care in psoriatic arthritis: a multidisciplinary E uropean perspective on improving the patient experience . Journal of the European Academy of Dermatology and Venereology 30:4, pages 576-585.
Crossref
Yaling Yang, John Brazier & Louise Longworth. (2014) EQ-5D in skin conditions: an assessment of validity and responsiveness. The European Journal of Health Economics 16:9, pages 927-939.
Crossref
Nihal Tezel, Ozlem Yilmaz Tasdelen, Hatice Bodur, Ulker Gul, Seray Kulcu Cakmak, Isil Deniz Oguz & Erdem Karabulut. (2015) Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone?. International Journal of Rheumatic Diseases 18:1, pages 63-69.
Crossref
Fanni Rencz, Valentin Brodszky, Márta Péntek, Orsolya Balogh, Éva Remenyik, Andrea Szegedi, Péter Holló, Sarolta Kárpáti, Hajnalka Jókai, Krisztina Herszényi, Emese Herédi, Sándor Szántó & László Gulácsi. (2014) Disease burden of psoriasis associated with psoriatic arthritis in Hungary. Orvosi Hetilap 155:48, pages 1913-1921.
Crossref
Juan Carlos Torre-Alonso, Jordi Gratacós, José Santos Rey-Rey, Juan Pablo Valdazo de Diego, Ana Urriticoechea-Arana, Esteban Daudén, Mireia Moreno, Pedro Zarco-Montejo, Eduardo Collantes-Estévez & Juan Antonio Fernández-López. (2014) Development and Validation of a New Instrument to Measure Health-related Quality of Life in Patients with Psoriatic Arthritis: The VITACORA-19. The Journal of Rheumatology 41:10, pages 2008-2017.
Crossref
Laure Gossec, Maarten de Wit, Uta Kiltz, Juergen Braun, Umut Kalyoncu, Rossana Scrivo, Mara Maccarone, Laurence Carton, Kati Otsa, Imre Sooäär, Turid Heiberg, Heidi Bertheussen, Juan D Cañete, Anselm Sánchez Lombarte, Andra Balanescu, Alina Dinte, Kurt de Vlam, Josef S Smolen, Tanja Stamm, Dora Niedermayer, Gabor Békés, Douglas Veale, Philip Helliwell, Andrew Parkinson, Thomas Luger & Tore K Kvien. (2014) A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Annals of the Rheumatic Diseases 73:6, pages 1012-1019.
Crossref
William Tillett, Ade Adebajo, Mel Brooke, Willemina Campbell, Laura C. Coates, Oliver FitzGerald, Laure Gossec, Philip Helliwell, Sarah Hewlett, Jana James, Patricia Minnock, Aisling Reast, Dennis O’Sullivan, Maarten de Wit & Neil McHugh. (2014) Patient Involvement in Outcome Measures for Psoriatic Arthritis. Current Rheumatology Reports 16:5.
Crossref
Emese Herédi, Fanni Rencz, Orsolya Balogh, László Gulácsi, Krisztina Herszényi, Péter Holló, Hajnalka Jókai, Sarolta Kárpáti, Márta Péntek, Éva Remenyik, Andrea Szegedi & Valentin Brodszky. (2014) Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary. The European Journal of Health Economics 15:S1, pages 111-119.
Crossref
Jordi Gratacós, Esteban Daudén, Juan Gómez-Reino, José Carlos Moreno, Miguel Ángel Casado & Vicente Rodríguez-Valverde. (2014) Health-related quality of life in psoriatic arthritis patients in Spain. Reumatología Clínica (English Edition) 10:1, pages 25-31.
Crossref
Jordi Gratacós, Esteban Daudén, Juan Gómez-Reino, José Carlos Moreno, Miguel Ángel Casado & Vicente Rodríguez-Valverde. (2014) Health-related quality of life in psoriatic arthritis patients in Spain. Reumatología Clínica 10:1, pages 25-31.
Crossref
Euthalia Roussou, Sunil Chopra & Danny Lunda Ngandu. (2012) Phenotypic and clinical differences between Caucasian and South Asian patients with psoriatic arthritis living in North East London. Clinical Rheumatology 32:5, pages 591-599.
Crossref
Ewa Orlewska. (2011) Challenges and changes in the Polish healthcare system. Society and Economy 33:3, pages 575-594.
Crossref
Monique A. M. Gignac, Xingshan Cao, Jessica Mcalpine & Elizabeth M. Badley. (2011) Measures of disability: Arthritis Impact Measurement Scales 2 (AIMS2), Arthritis Impact Measurement Scales 2-Short Form (AIMS2-SF), The Organization for Economic Cooperation and Development (OECD) Long-Term Disability (LTD) Questionnaire, EQ-5D, World Hea. Arthritis Care & Research 63:S11, pages S308-S324.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.